Relay Therapeutics Inc
(RLAY)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Sales | 10,007 | 25,546 | 1,381 | 3,029 | 82,654 |
| Gross Profit | 10,007 | 25,546 | 1,381 | 3,029 | 82,654 |
| Operating Expenses | 382,475 | 398,546 | 300,656 | 367,727 | 138,450 |
| Operating Income | -372,468 | -373,000 | -299,275 | -364,698 | -55,796 |
| Other Income | 34,760 | 31,027 | 8,766 | 826 | 3,384 |
| Pre-tax Income | -337,708 | -341,973 | -290,509 | -363,872 | -52,412 |
| Net Income Continuous | -337,708 | -341,973 | -290,509 | -363,872 | -52,412 |
| Net Income | $-337,708 | $-341,973 | $-290,509 | $-363,872 | $-52,412 |
| EPS Basic Total Ops | -2.36 | -2.79 | -2.59 | -3.82 | -5.40 |
| EPS Basic Continuous Ops | -2.36 | -2.79 | -2.59 | -3.82 | -1.23 |
| EPS Diluted Total Ops | -2.36 | -2.79 | -2.59 | -3.82 | -5.40 |
| EPS Diluted Continuous Ops | -2.36 | -2.79 | -2.59 | -3.82 | -1.23 |
| EPS Diluted Before Non-Recurring Items | -2.36 | -2.79 | -2.69 | -2.70 | N/A |
| EBITDA(a) | $-379,319 | $-378,494 | $-293,963 | $-358,721 | $-52,663 |